It was found that depletion of CHD4 is synergistic with DNMT inhibition in reducing the viability of colon cancer cells in correlation with reactivation of tumor suppressor, suggesting that their combined inhibition may be beneficial for the treatment of colon cancer. Here, DNMT1 is linked to malignant colon neoplasm.